| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.0045 | 1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.00026 | 1 |